Samenvatting

Older(40+)people with cystic fibrosis(PWCF) were not expected to survive into adulthood. Life expectancy has improved to an mean survival age of50+ due to a multidisciplinary approach and modulator therapy. Along with these new developments an improved quality of life(QoL) has been observed. With an increased survival certain issues related to longevity are likely to emerge.
Originele taal-2English
Pagina's (van-tot)S183
TijdschriftJ Cyst Fibros
Volume22
Nummer van het tijdschriftsupp 2
DOI's
StatusPublished - jun. 2023
Evenement46th European Cystic Fibrosis conference 2023 - vienna, Austria
Duur: 7 jun. 202310 jun. 2023

Vingerafdruk

Duik in de onderzoeksthema's van 'Ageing with cystic fibrosis: challenges for patients and team members'. Samen vormen ze een unieke vingerafdruk.

Citeer dit